Skip to main content

ORBIMED ADVISORS LLC

Location
New York, NY
Portfolio Value
Mid $5,124,541,261
Diversification
Diversified
Reports for
ORBIMED CAPITAL LLC
Filing Date
Global Rank
#732 / 8,700 ▲ 86
Top Industry
Biotechnology 72.2%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020

Portfolio Concentration

116 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026
Top Position
12.3%
+2.1 pts
Top 5
32.1%
+0.9 pts
Top 10
42.7%
−2.1 pts
HHI
337
Sep 2023 → Jun 2026 · range 252 – 377
Diversified+21

Portfolio Trend

26 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026
Sector % Portfolio Value
Healthcare 100.0% $5,124,541,261

Last Quarter's Activity

Export CSV
Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased
25 positions
Ticker Δ Shares Shares Value Open
+380,750 1,577,705 $33,526,231

Trimmed

Positions the filer reduced
25 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
25 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
23 positions
Ticker Shares Value Open
100,000 $0
94,400 $0
10,570,300 $0

Portfolio Positions

Export CSV View 13F filing
116 tracked positions · $5,124,541,261 total · filing declares 129 positions · $5,396,779,685 · as of Jun 30, 2026
Showing 1–50 of 116 positions by value · page 1 of 3
Ticker Company Shares Value (USD) % of Portfolio History
1,577,705 $33,526,231 0.65%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.